Program Name 
Novartis Malaria Initiative
Organized By
Novartis Healthcare Philippines, Inc.
Partners
- World Health Organization (WHO)
- Department of Health (DOH)
- Local Government Units (LGUs)
- Malaria advocacy groups
- Pilipinas Shell Foundation, Inc.
Year Launched
2002
Target Condition
Malaria
Who Benefits From the Program
Underprivileged patients suffering from malaria, particularly those in malaria-endemic areas.
Program Overview
The Novartis Malaria Initiative, launched in 2002 in the Philippines, is part of a global effort by Novartis Healthcare and the World Health Organization (WHO) to combat malaria in developing countries. The initiative provides access to Coartem® (a combination of artemether and lumefantrine), a breakthrough anti-malaria drug, at cost through public health systems.
The program began in 2001 as a 10-year alliance between Novartis and WHO to distribute affordable anti-malaria treatments to malaria-endemic countries. Over the years, it has grown into one of the most extensive and successful access-to-medicines programs worldwide, providing over 400 million treatments in more than 60 malaria-endemic countries globally. It is estimated that this effort has saved 1 million lives, most of them infants and children.
Since its local launch in 2002, the Novartis Malaria Initiative has distributed 172,260 treatments to Filipino patients at cost, saving an estimated 43,000 lives. This effort aligns with the Millennium Development Goal (MDG) Target No. 8, which seeks to improve access to essential medicines for neglected tropical diseases in developing nations.
Where to Seek Help or Access the Program
Patients can visit their Municipal or City Health Center to learn more about the program or access malaria treatment.
For Questions or Assistance
Patients are encouraged to contact their nearest Municipal or City Health Center for information about the Malaria Initiative and available services.
Closing Thoughts
The Novartis Malaria Initiative demonstrates the power of collaboration in addressing global health challenges. Through its partnerships with WHO, local governments, and advocacy groups, the initiative has made significant strides in reducing the burden of malaria in the Philippines and worldwide. Access to affordable, effective treatments like Coartem® continues to save lives and pave the way for a healthier future.
